Arnold L Oronsky's Net Worth

$452 Million

Estimate Recalculated Feb 22, 2024 04:19PM EST

Who is Arnold L Oronsky?

Arnold L Oronsky has an estimated net worth of $452 Million. This is based on reported shares across multiple companies, which include EnteroMedics Inc, INTRALASE CORP, Invuity, Inc., Trius Therapeutics Inc, GLAUKOS Corp, Eiger BioPharmaceuticals, Inc., KalVista Pharmaceuticals, Inc., Marketo, Inc., OBALON THERAPEUTICS INC, Venus Concept Inc., Transcept Pharmaceuticals Inc, EPOCRATES INC, METABASIS THERAPEUTICS INC, AVEDRO INC, DYNAVAX TECHNOLOGIES CORP, ANESIVA, INC., PMV Pharmaceuticals, Inc., MACROGENICS INC, TESARO, Inc., APPLIED GENETIC TECHNOLOGIES CORP, MYOGEN INC, and CORIXA CORP.

SEC CIK

Arnold L Oronsky's CIK is 0001207833

Past Insider Trading and Trends

2014 was Arnold L Oronsky's most active year for acquiring shares with 39 total transactions. Arnold L Oronsky's most active month to acquire stocks was the month of May. 2005 was Arnold L Oronsky's most active year for disposing of shares, totalling 45 transactions. Arnold L Oronsky's most active month to dispose stocks was the month of October. 2007 saw Arnold L Oronsky paying a total of $9,500,001.45 for 3,552,070 shares, this is the most they've acquired in one year. In 2013 Arnold L Oronsky cashed out on 40,770,500 shares for a total of $70,818,664.12, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

EnteroMedics Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+724.94%
1.36M
1.55M
Nov 20
Form 4
187.5K
$8.00
$1,500,000.00
187.5K
Nov 15
Form 3
0
0
No matching records found

INTRALASE CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-49.64%
-1.68M
1.71M
Jun 7
Form 4
3.39M
3.39M
Oct 13
Form 3
0
0
No matching records found

Invuity, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
1.08M
1.08M
Jun 18
Form 3
0
0
No matching records found

Trius Therapeutics Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
3.55M
$4.77
3.55M
Aug 6
Form 3
0
0
No matching records found

GLAUKOS Corp (GKOS) Snapshot price: $94.715

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.6M
2.6M
Jun 30
Form 3
0
0
No matching records found